Location: Home > Pharma China Web Edition
  • search
  • go
  • News in Focus
  • 10/21/2025ESMO 2025 Highlights China's Strategic Leap in Oncology Innovation
  • 10/13/2025U.S. Senate Approves Revised China Biotech Competition Bill with Softe...
  • 10/13/2025China's Innovative Drug Sector Secures Over CNY 4.2B in Q3 Financing, ...
  • 9/22/2025China's Role in Global Drug Approvals Expands as Regulatory Timelines ...
  • 9/19/2025​​​​​​​China Biopharma at Crossroads: A Mid-2025 Tale of Contra...
  • 9/19/2025Gottlieb Cautions Blanket China Drug Licensing Ban amid Calls for Rigo...
  • 9/2/2025China's Clinical Trial Quality Management Faces Key Challenges Despite...
  • 8/27/2025AstraZeneca Bounces Back from Scandal in China with $2.5B R&D Push
  • 8/27/2025Global Pharma Funnels $48.5B into Chinese Biotech Partnerships in H120...
  • 8/22/2025Premier Li Visits BeOne, Signaling China's Strategic Push for Biotech ...
  • 8/14/2025China Sees Surge in Innovative Drug Approvals in H1, Covering Cancer, ...
  • 7/1/2025China Launches Landmark Measures to Boost Innovative Drug Industry, Se...
  • 6/25/2025Breaking the Boundaries: A New Map of Physician Behavior in China's Di...
  • 6/19/2025CDE Annual Report Reveals Strong Growth and Evolving Focus in China's ...
  • 6/17/2025China Emerges as Prime Global Target for Multinationals in Biotech Dea...
  • 4/26/2025China Aims for Significant Pharma Industry Digital Transformation by 2...
  • 4/25/2025MNC Pharma's Q1/2025 China Performance: Divergent Fortunes Amid Pricin...
  • 4/22/2025China Broadens Healthcare Access: Foreign Doctors and Drug Import Refo...
  • Page:1/1 Total number of articles:18: [First][<<] [1] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group